Growth hormone effects on insulin-making cells in prediabetes
Part of Hormones & metabolism clinical trials.
This study looks at how growth hormone affects the cells in your pancreas that make insulin. It may help find new ways to prevent type 2 diabetes in people with prediabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between the ages of 18 and 70.
- Your BMI must be between 18.5 and 45.9.
- You must have prediabetes (blood sugar levels higher than normal, but not yet in the diabetes range).
- You cannot be pregnant, planning to get pregnant, or breastfeeding during the study.
- You cannot have been diagnosed with type 1 or type 2 diabetes.
- You cannot be taking certain medications that affect blood sugar (like GLP-1 receptor agonists).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how growth hormone affects insulin-making cells in people at risk for type 2 diabetes. It may help explain why some people with a family history of diabetes develop the condition.
This study looks at how the body's insulin-making cells (beta cells) might become resistant to growth hormone after a full-term pregnancy. It compares women who had gestational diabetes to those who didn't, to learn more about diabetes risk. You may join if you had a healthy single-baby pregnancy in the last 5 years and never had type 1 or type 2 diabetes.
This study looks at adults with prediabetes—specifically abnormal fasting and/or 2-hour blood sugar tests—to see whether a treatment helps improve sugar control. You may also be compared with people who have normal blood sugar (the control group).
This study tracks how blood sugar levels change in people with prediabetes (higher-than-normal blood sugar but not yet diabetes). Researchers will use a small sensor to monitor your blood sugar and help understand what affects it, which could help prevent or delay type 2 diabetes.
This study tests how growth hormone (GH) and liraglutide affect a hunger-related hormone system called AgRP. It compares effects in healthy people (lean or overweight) and in people with isolated GH deficiency, aiming to understand how these treatments change appetite and metabolism.
This study uses a smartphone app to track and help manage blood sugar levels in people with prediabetes, potentially preventing the progression to diabetes. It also studies different types of prediabetes to provide personalized care.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.